Package 0406-5125-01

Brand: lisdexamfetamine dimesylate

Generic: lisdexamfetamine dimesylate
NDC Package

Package Facts

Identity

Package NDC 0406-5125-01
Digits Only 0406512501
Product NDC 0406-5125
Product ID 0406-5125_02215a03-fa4d-4785-9d38-4f22d92faf31
Description

100 TABLET, CHEWABLE in 1 BOTTLE (0406-5125-01)

Marketing

Marketing Status
Marketed Since 2024-12-17
Brand lisdexamfetamine dimesylate
Generic lisdexamfetamine dimesylate
Sample Package No

Linked Drug Pages (1)

Lisdexamfetamine Dimesylate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "02215a03-fa4d-4785-9d38-4f22d92faf31", "openfda": {"upc": ["0304065125013", "0304065128014", "0304065126010", "0304065127017", "0304065129011", "0304065124016"], "unii": ["SJT761GEGS"], "rxcui": ["1871456", "1871460", "1871462", "1871464", "1871466", "1871468"], "spl_set_id": ["3a79b2ab-4131-4978-99a0-0119df57d5fe"], "manufacturer_name": ["SpecGx LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, CHEWABLE in 1 BOTTLE (0406-5125-01)", "package_ndc": "0406-5125-01", "marketing_start_date": "20241217"}], "brand_name": "Lisdexamfetamine Dimesylate", "product_id": "0406-5125_02215a03-fa4d-4785-9d38-4f22d92faf31", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "0406-5125", "dea_schedule": "CII", "generic_name": "Lisdexamfetamine Dimesylate", "labeler_name": "SpecGx LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisdexamfetamine Dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "20 mg/1"}], "application_number": "ANDA218850", "marketing_category": "ANDA", "marketing_start_date": "20241217", "listing_expiration_date": "20261231"}